Further, UDCA was found to improve NASH, insulin resistance, and high-fat diet (HFD)-induced obesity through suppression of FXR signaling, which is manifested by a significant reduction of FXR and fibroblast growth factor 19 (FGF19) levels coupled with elevation of cholesterol 7α-hydroxylase (CYP7A1) expression in the intestine (17). The gene discussed is CYP7A1; the disease is obesity disorder.